✦ LIBER ✦

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

✍ Scribed by on behalf of the Aripiprazole Study Group; Daniel E. Casey; William H. Carson; Anutosh R. Saha; Amy Liebeskind; Mirza W. Ali; Darlene Jody; Gary G. Ingenito

Book ID: 105880312
Publisher: Springer
Year: 2003
Tongue: English
Weight: 209 KB
Volume: 166
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-002-1344-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A non-randomized study to investigate th

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

✍ Frank C Schieber; David W Boulton; Alfred H Balch; Robert Croop; Suresh Mallikaa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## Objective To determine the effect of aripiprazole on steady‐state pharmacokinetics of lamotrigine in patients with bipolar I disorder who were clinically stable on lamotrigine (100–400 mg/day) for ≥4 weeks. ## Methods In this open‐label study, aripiprazole was administered at 10 m

Efficacy of aripiprazole adjunctive to l

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

✍ Ronald Marcus; Arif Khan; Linda Rollin; Beth Morris; Karen Timko; William Carson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

Early switching from morphine to methado

Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study

✍ Daniel I. G. Cubero; Auro del Giglio 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 167 KB

How effective is it to sequentially swit

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?—A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting

✍ Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Kensuke Nomura; Hiroyoshi T 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 199 KB

Outcomes after switching from one anti–t

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

✍ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres